Patent · US Active

Polynucleotides encoding polypeptides and methods using same

US7939634B2 · kind B2 · utility

5Cited by

5References

5Claims

0Family size

Assignee

Compugen Ltd. · IL

Inventors

Michal Ayalon-Soffer · Ramat HaSharon, IL
Zurit Levine · Herzliya, IL
Osnat Sella-Tavor · Ein Mahel, IL
Alex Diber · Rishon LeZion, IL
Ronen Shemesh · Holon, IL
Amir Toporik · Holon, IL
Galit Rotman · Herzliya, IL
Sergey Nemzer · Raanana, IL
Avi Rosenberg · Kfar Sava, IL
Dvir Dahary · Nes Ziona, IL
Assaf Wool · Kiryat Ono, IL
Gad S. Cojocaru · Ramat HaSharon, IL
Pinchas Akiva · Ramat Gan, IL
Sarah Pollock · Nes Ziona, IL
Kinneret Savitsky · Nes Ziona, IL
Jeanne Bernstein · Kfar Yona, IL

Key dates

Filing date	Jan 27, 2005
Grant date	May 10, 2011
Priority date	—
Expiry date	Jul 4, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/81
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel polypeptides and polynucleotides encoding same are provided. Also provided methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention. Also provided are methods and kits for diagnosing, determining predisposition and/or prognosis of various disorders using as diagnostic markers the novel polypeptides and polynucleotides of the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.